Systemic lupus erythematosus and anticardiolipin antibodies in Klinefelter's syndrome. 1995

S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
Department of Dermatology, Nara Medical University, Japan.

UI MeSH Term Description Entries
D007713 Klinefelter Syndrome A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.). 48,XXYY Syndrome,49,XXXXY Syndrome,Klinefelter Syndrome, Variants,Klinefelter's Syndrome,XXXY Males,XXY Syndrome,XXY Trisomy,Xxyy Syndrome,Klinefelter Syndromes,Klinefelter Syndromes, Variants,Klinefelters Syndrome,Syndrome, Klinefelter,Syndrome, Klinefelter's,Syndrome, Variants Klinefelter,Syndrome, XXY,Syndrome, Xxyy,Syndromes, Klinefelter,Syndromes, Variants Klinefelter,Syndromes, XXY,Syndromes, Xxyy,Trisomies, XXY,Trisomy, XXY,XXXY Male,XXY Syndromes,XXY Trisomies,Xxyy Syndromes
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001157 Arterial Occlusive Diseases Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. Arterial Obstructive Diseases,Arterial Occlusion,Arterial Obstructive Disease,Arterial Occlusions,Arterial Occlusive Disease,Disease, Arterial Obstructive,Disease, Arterial Occlusive,Obstructive Disease, Arterial,Occlusion, Arterial,Occlusive Disease, Arterial
D016491 Peripheral Vascular Diseases Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART. Peripheral Angiopathies,Vascular Diseases, Peripheral,Diseases, Peripheral Vascular,Angiopathies, Peripheral,Angiopathy, Peripheral,Disease, Peripheral Vascular,Peripheral Angiopathy,Peripheral Vascular Disease,Vascular Disease, Peripheral
D017153 Antibodies, Anticardiolipin Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN. Anticardiolipin Antibodies,Anticardiolipin Autoantibodies,Anticardiolipin Autoantibody,Cardiolipin Autoantibodies,Cardiolipin Autoantibody,Anticardiolipin Antibody,Antibody, Anticardiolipin,Autoantibody, Anticardiolipin,Autoantibody, Cardiolipin

Related Publications

S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
August 1985, Journal of the Royal Society of Medicine,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
March 1989, Medicina clinica,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
November 1992, The Journal of rheumatology,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 1989, Cleveland Clinic journal of medicine,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 1986, Acta haematologica,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 1994, The National medical journal of India,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 1988, The American journal of medicine,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 1980, Arthritis and rheumatism,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 1977, Arthritis and rheumatism,
S Miyagawa, and E Matsuura, and W Kitamura, and H Ohno, and K Kichikawa, and H Uchida, and T Shirai, and S Okamoto
January 2000, Clinical and experimental rheumatology,
Copied contents to your clipboard!